Lowrey Gillian E, Henderson Neil, Blakey John D, Corne Jonathan M, Johnson Simon R
Nottingham University Hospitals NHS Trust, Nottingham, UK.
Respir Med. 2008 Jun;102(6):845-51. doi: 10.1016/j.rmed.2008.01.006. Epub 2008 Mar 6.
Animal and human studies have implicated an imbalance of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) in the pathogenesis of chronic obstructive pulmonary disease (COPD). MMP-9 protein is increased in COPD and we hypothesized that total MMP activity would be raised although this has not previously been measured.
Using fluorescence and biotin labelled MMP assays, RT-PCR, western blotting and enzyme-linked immunosorbent assay we examined total MMP activity, specific gelatinase, elastase, collagenase activity, TIMP-1 and TIMP-2 in induced sputum from smokers with COPD and smokers without COPD.
Induced sputum was obtained from 15 smokers with COPD and 14 smokers without COPD. MMP-9 levels were higher in those with COPD compared with controls (p<0.05). Total MMP activity, specific gelatinase, collagenase and elastase activities were not higher in COPD patients. In addition, reduced MMP activity was correlated with increasing airflow obstruction in COPD (p=0.016).
MMP-9 protein but not MMP activity was higher in sputum of COPD patients compared with controls. These results suggest that MMP-9 levels may not reflect the overall MMP activity in the airways of patients with COPD suggesting a complex relationship between MMP-9 protein and activity. Further studies of MMPs in COPD should comprise activity measures in addition to protein levels.
动物和人体研究表明,基质金属蛋白酶(MMPs)与基质金属蛋白酶组织抑制剂(TIMPs)失衡与慢性阻塞性肺疾病(COPD)的发病机制有关。COPD患者体内MMP-9蛋白水平升高,我们推测尽管此前未进行过测量,但总的MMP活性会升高。
我们使用荧光和生物素标记的MMP检测、逆转录聚合酶链反应(RT-PCR)、蛋白质印迹法和酶联免疫吸附测定法,检测了慢性阻塞性肺疾病吸烟者和非慢性阻塞性肺疾病吸烟者诱导痰中的总MMP活性、特异性明胶酶、弹性蛋白酶、胶原酶活性、TIMP-1和TIMP-2。
从15名慢性阻塞性肺疾病吸烟者和14名非慢性阻塞性肺疾病吸烟者中获取诱导痰。与对照组相比,慢性阻塞性肺疾病患者的MMP-9水平更高(p<0.05)。慢性阻塞性肺疾病患者的总MMP活性、特异性明胶酶、胶原酶和弹性蛋白酶活性并未升高。此外,慢性阻塞性肺疾病患者中MMP活性降低与气流阻塞增加相关(p=0.016)。
与对照组相比,慢性阻塞性肺疾病患者痰液中的MMP-9蛋白水平更高,但MMP活性并未升高。这些结果表明,MMP-9水平可能无法反映慢性阻塞性肺疾病患者气道中的总体MMP活性,提示MMP-9蛋白与活性之间存在复杂关系。对慢性阻塞性肺疾病中MMPs的进一步研究除了蛋白质水平外,还应包括活性测定。